ISSN (Print): 1871-5257
ISSN (Online): 1875-6182
Volume 18, 2 Issues, 2020
Download PDF Flyer
Open Access Funding
Promote Your Article
ISSN (Print): 1871-5257
ISSN (Online): 1875-6182
Aims & Scope
MEDLINE/PubMed/Index Medicus, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, EMBASE/Excerpta Medica, Chemical Abstracts Service/SciFinder, ProQuest, ChemWeb, Google Scholar, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, PubsHub, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, British Library, Ulrich's Periodicals Directory and JournalTOCs.
Submit Abstracts / Manuscripts Online
Animated Abstract Submission
View Full Editorial Board
Self Archiving Policies
Instructions for Authors
Free Copies Online
Open Access Articles
Most Cited Articles
Advertise With Us
Most Accessed Articles
Most Popular Articles
Special Issue Submission
Editor(s): Giuseppe Rizzo
Co-Editor(s): Domenico Arduini
eISBN: 978-1-60805-044-4, 2010
Congenital heart defects (CHD) are the most frequent malformation in the human fetus and are the leading cause of mortality due to malformations in the first year of life. Despite its clinical importance screening performed by ultrasonographic examination during the second trimester of pregnancy has shown disappointingly low detection rates mainly due to the difficulties in obtaining an adequate examination of the fetal heart. Four-dimensional (4D) ultrasound of the fetal heart has been recently suggested as a tool to improve the detection rate of CHD by decreasing the dependency on operator skills required in two-dimensional ultrasound scans but up to now no practical manuals are available in describing its application in clinical practice for the study of fetal heart. The objective of this Ebook is to explain the role of 4D during second trimester examination and in fetuses with CHD. T
Editor(s): Peter M. Schofield
eISBN: 978-1-60805-119-9, 2011
Historically, patients with advanced structural heart disease have required major surgery to correct the defect. This includes, for example, patients with atrial septal defect, aortic valve disease and mitral valve disease. In recent years there have been major advances in the treatment of patients with structural heart disease using minimally invasive, percutaneous treatments. This field continues to evolve quite quickly.
This e-book outlines the current situation with respect to minimally invasive treatment of a wide range of structural cardiac defects. Each chapter covers details of a structural defect and outlines various technologies available for treating the condition. Indications for procedures as well as details of the procedures are also provided wherever possible. This e-book should be a useful reference for readers interested in minimally invasive cardiovascular surgery.
Author(s): Lise Lund Håheim
eISBN: 978-1-60805-232-5, 2011
This book provides a comprehensive overview of current knowledge about research in oral infections and their association with cardiovascular diseases. Several epidemiological, clinical and other scientific aspects are covered in this book through the work of medical experts.
The detailed accounts in this book are of great value to readers in the scientific community, practitioners, teachers and students in relevant fields, and health-care planners.
Editor(s): Ignasi Anguera Camós
eISBN: 978-1-60805-030-7, 2011
In recent decades, the prevalence of heart failure has steadily increased and can be considered a contemporary cardiovascular epidemic. Therefore, treatment of heart failure is a primary focus of cardiovascular disease management strategies. Cardiac resynchronization therapy: an established pacing therapy for heart failure and mechanical dyssynchrony provides basic knowledge about congestive heart failure and also covers the evolution of cardiac resynchronization therapy. State-of-the-art information and future directions of this therapeutic tool are explained. As cardiac resynchronization therapy (CRT) is a new therapy which still undergoes rapid advancement, it is imperative to provide updates on key issues. These include technological advances, the unique role of imaging to assess mechanical dyssynchrony, troubleshooting, recent key clinical trials, and the incorporation of monitoring capabilities into CRT or CRT plus defibrillation devices. Cardiac resynchronization therapy is an exciting new option for a growing number of heart failure patients, but CRT systems present special challenges to clinicians, even those accustomed to working with pacemakers.
Author(s): Andy Petroianu
eISBN: 978-1-60805-273-8, 2011
The spleen is an organ responsible for many biological functions, such as immunological defense, the removal of foreign particles from the blood stream, the metabolism of bilirubins, lipids and several amino acids, the control of the number and maturity of blood leukocytes and platelets and haematopoesis.
This book is a collection of medical methods written exclusively to show the spleen in relation to basic sciences (anatomy and physiology) and related clinical practice and is a useful resource for clinical physicians, haematologists, oncologists, general surgeons, oncologic surgeons, trauma surgeons, resident physicians and medical students.
Author(s): Zhiguo Wang
eISBN: 978-1-60805-184-7, 2010
Micro RNAs (miRNAs) are known to play an important role in gene expression regulation. Owing to their ever-increasing implications in the control of various biological and pathological processes, miRNAs have now been considered novel biomarkers of various human diseases including, cancer, viral disease, cardiovascular disorders, metabolic disturbances, etc. Unique expression profiles have been associated with specific pathological states.
Cardiovascular disease is among the main causes of mortality in developed countries. The pathological process of the heart is associated with altered expression profile of genes that are important for cardiac function. The implications of miRNAs in the pathological process of the cardiovascular system have recently been recognized, and the research on miRNAs in relation to cardiovascular disease is now in rapid progress. The aim of this ebook is to present updated research on the subject with analyses from published reports. Micro RNAs and Cardiovascular Disease caters to the growing interest and information needs of cardiac clinicians and gene expression researchers.
Editor(s): Salvatore Novo
Co-Editor(s): Jawed Fareed, Evi Kalodiki and Jeanine M. Walenga
eISBN: 978-1-60805-221-9, 2012
The simple assessment of atherosclerotic risk factors is not an accurate tool to predict the risk of cardiovascular disease (CVD) in adults without past history of atherosclerotic disease. Preclinical atherosclerotic increases the global cardiovascular risk and should be evaluated for a better risk stratification. Intima-media thickness (IMT), reduced ankle-brachial pressure index (ABI) and impaired flow mediated dilatation (FMD) are independent markers of multifocal but subclinical atherosclerosis and result associated with an increased rate of cardiovascular events. Multidetector computed tomography (MDCT) may be a useful non-invasive technique to detect silent coronary disease (CAD) in patients with peripheral preclinical atherosclerosis. This ebook outlines “preclinical athersclerosis” and its markers in clinical practice. The ebook gives simple but clear information for a better stratification of global cardiovascular risk. The text serves as an important guide for medical professionals involved in the management of cardiovascular patients.
Editor(s): Giuseppe Santoro, Giuseppe Pacileo and Maria Giovanna Russo
eISBN: 978-1-60805-226-4, 2012
Congenital heart diseases are the most common neonatal malformations, ranging from 8 to 15/1000 live births in various communities. Improvement of knowledge in the genetic and etio-pathogenic aspects of these malformations as well as the technical advances of diagnostic and therapeutic tools have brought about a significant improvement in overall long-term patient outcome over the last few decades. This e-book is an update on the most recent genetic, diagnostic and therapeutic aspects of this pediatric cardiology. Specifically, the book explains, in detail, recent acquisitions in the field of interaction between the genome and heart development, advances in diagnostic non-invasive techniques and novel therapeutic applications of the percutaneous and “hybrid” cardiologic/surgical procedures. These developments in diagnostics and therapeutics will be extremely valuable for both pediatric and adult cardiologists treating patients with congenital heart defects.
Author(s): Wilhelm Peter Mistiaen
eISBN: 978-1-60805-287-5, 2012
"Degenerative aortic valve disease is the most prominent cardiac valve disease in Western societies. This volume describes some of the more important issues and problems for this condition: its progressive character and the underlying mechanisms of this progression diagnostic difficulties 1) ascertainment of valvular origin of symptoms in elderly; 2) the challenge of the low output – low gradient syndrome; 3) moderate aortic valve calcification during CABG; 4) prediction of the rate of progression (who will need surgery on short term and who not). the burden on the left ventricle and its consequences (danger of postponement of surgery) the effect and the modalities (access, types of valves) of surgical treatment on survival (and QoL) the mode of registering postoperative complications determining predictors for valve related, non-valve related cardiac and non-cardiac postoperative complications. The e-book is a unique presentation, specific to degenerative aortic valve disease and its treatment including information about ways to deal with the progressive character of the disease (autophagy as a mode of cell death). Cardiologists still avoid or delay referring patients to the surgeon for the sake of age, left ventricular function or co-morbidity. Therefore, the e-book benefits readers by addressing the above issue and providing critical information for changing referral policy, which would ultimately enhance postoperative survival of patients suffering from heart valve disease."
Author(s): Jean-Jacques Goy, Jean-Christophe Stauffer, Jürg Schlaepfer and Pierre Christeler
eISBN: 978-1-60805-479-4, 2013
This e-book starts with a comprehensive overview of the basic principles in Electrocardiography (ECG) with just enough depth to lift the reader above the crowd when it comes to understanding the physics behind ECG. Subsequent chapters provide an approach to the analysis of the ECG. The most important followed by sections with insight into conduction abnormalities, arrhythmia, and myocardial ischemia. The e-book has a straightforward layout, a very clear format, and abundant ECG tracings for interested readers. The diagnostic algorithms provided in the volume prove to be very useful in daily medical practice. Overall, the e-book will help novice physicians, students and fellows to improve their knowledge in ECG interpretation.
Electrocardiography (ECG) is, therefore, a very attractive book for all levels of physicians and health-care professionals interested in ECG and it is a welcome addition to the medical literature.
Editor(s): Christakis Constantinides
eISBN: 978-1-60805-806-8, 2014
ISBN: 978-1-60805-807-5 ISSN: 2351-9843 (Print)
eISBN: 978-1-60805-858-7, 2014
ISBN: 978-1-60805-859-4 ISSN: 2352-3239 (Print)
Frontiers in Clinical Drug Research – Hematology is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.
The first volume of this series features 6 chapters that cover a variety of topics including: Computational methods, molecular docking, and molecular dynamics simulation Recent advances in the treatment of Beta-Thalassemia Major Research on multiple myeloma and leukemia Molecular imaging in hematology